DKSH Acquires Rocephin From Roche
DKSH says it acquired Rocephin from Roche, expanding its healthcare own-brands portfolio.
Story updates
06:05:28 AM UTC
SquawkNews
DKSH Acquires Rocephin Rights From Roche in More Than 80 Markets DKSH on October 28, 2026, annou
06:09:18 AM UTC
SquawkNews
DKSH Management Ltd./ Key word(s): AcquisitionDKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin® From Roche28.10.2026 / 07:00 CET/CESTMedia releaseDKSH has acquired the rights for Rocephin® from Roche across more than 80 markets. Following the acquisition of Meliane®…
06:09:35 AM UTC
SquawkNews
DKSH Holding Ltd. acquired rights to Rocephin (ceftriaxone) from Roche across 80+ markets. The brand generated approximately CHF 61M net sales in 2025.Material DetailsContext by AI AnalystThis is a continuation of DKSH Healthcare’s shift toward higher-value Own Brands after the Meliane deal. A larg…